Peter Probst
18Patents
7h-index
27Co-inventors
66Inventor score
Filing activity: Feb 12, 1998 → Mar 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8377448B2 | CD47 related compositions and methods for treating immunological diseases and disorders | Chemistry; Metallurgy | 23 | Active |
| US6166177A | Compounds and methods for the treatment and diagnosis of chlamydial infection | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6432916B1 | Compounds and methods for treatment and diagnosis of chlamydial infection | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6447779B1 | Compounds for the diagnosis of Chlamydial infection | Chemistry; Metallurgy | 10 | Expired |
| US7384638B2 | Compounds and methods for treatment and diagnosis of Chlamydial infection | Chemistry; Metallurgy | 9 | Expired |
| US6638517B2 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7462357B2 | Compounds and methods for treatment and diagnosis of chlamydial infection | Chemistry; Metallurgy | 7 | Expired |
| US6613337B1 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6375955B1 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6607731B1 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6555115B1 | Compounds and methods for treatment and diagnosis of chlamydial infection | Chemistry; Metallurgy | 4 | Expired |
| US8052975B2 | Compounds and methods for treatment and diagnosis of chlamydial infection | Chemistry; Metallurgy | 4 | Active |
| US8541007B2 | Vaccines against chlamydial infection | Human Necessities | 3 | Active |
| US8263089B2 | Compounds and methods for treatment and diagnosis of chlamydial infection | Chemistry; Metallurgy | 3 | Active |
| US11034770B2 | Immunomodulatory antibodies and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11634501B2 | Immunomodulatory antibodies and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11827715B2 | Human CD163 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12195549B2 | Immunomodulatory antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.